잠시만 기다려 주세요. 로딩중입니다.

Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria

Journal of Movement Disorders 2021년 14권 1호 p.1 ~ 9
소속 상세정보

Abstract


Perry disease is a hereditary neurodegenerative disease with autosomal dominant inheritance. It is characterized by parkinsonism, psychiatric symptoms, unexpected weight loss, central hypoventilation, and transactive-response DNA-binding protein of 43kD (TDP-43) aggregation in the brain. In 2009, Perry disease was found to be caused by dynactin I gene (DCTN1), which encodes dynactin subunit p150 on chromosome 2p, in patients with the disease. The dynactin complex is a motor protein that is associated with axonal transport. Presently, at least 8 mutations and 22 families have been reported; other than the “classic” syndrome, distinct phenotypes are recognized. The neuropathology of Perry disease reveals severe degeneration in the substantia nigra and TDP-43 inclusions in the basal ganglia and brain stem. How dysfunction of the dynactin molecule is related to TDP-43 pathology in Perry disease is important to elucidate the pathological mechanism and develop new treatment.

키워드

Dynactin I gene; Familial Parkinson’s disease; Perry disease; TDP-43 storage disease

원문 및 링크아웃 정보

 

등재저널 정보